BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 27, 2018
View Archived Issues
siRNA prevents pre-eclampsia in mice and primates
Read More
Anti-Andean antibodies protect postexposure
Read More
Imiquimod analogue fights more strains of Leishmania
Read More
Lung specificity means low tox for inhalable JAK inhibitor
Read More
Presepsin is a prognostic marker in congenital heart disease
Read More
Phase I results for PIN-201104 support progression to phase II for asthma
Read More
First dosing in phase Ib study of EDP-1815 in psoriasis and atopic dermatitis
Read More
miR-21 predicts functional worsening in children with CHD-associated pulmonary hypertension
Read More
European Commission approves Poteligeo for mycosis fungoides and Sezary syndrome
Read More
FDA grants accelerated approval to Vitrakvi for advanced solid tumors with NTRK gene fusion
Read More
HBV capsid assembly inhibitors discovered at Shanghai Longwood Biopharmaceuticals
Read More
Sanford Burnham Prebys Medical Discovery Institute identifies ACP1 inhibitors
Read More
REVOLUTION Medicines synthesizes rapamycin analogues
Read More
Cyclin-dependent kinase inhibitors patented by Selection Bioscience
Read More
Gene methylation of nontumoral liver tissue predicts recurrence of HCC after surgical resection
Read More
BAT-8001, a potent anti-HER2 antibody-drug conjugate, shows promising preclinical profile
Read More
Phase I study demonstrates bioequivalence of CT-P16 with the reference bevacizumab products
Read More
Aurigene presents AU-15330, a novel dual degrader of SMARCA2/4
Read More
G1 Therapeutics reports topline data from second phase II trial of trilaciclib in first-line SCLC
Read More
Belgian clearances for phase I trial of anti-IL-7 receptor antagonist OSE-127
Read More
Janssen initiates phase I study of live biotherapeutic product VE-202 for IBD
Read More
European Commission approves pegfilgrastim biosimilar Ziextenzo
Read More
FDA clears IND for phase I trial of AVID-200 in solid tumors
Read More
Vivace Therapeutics identifies YAP1/TEAD interaction inhibitors
Read More
New BTK inhibitors developed at the Korea Research Institute of Chemical Technology
Read More
Cortexyme patents gingipain R1/R2 inhibitors
Read More